HGH Frag 176–191 – Growth Hormone Fragment for Peptide Pathway Research
HGH Frag 176–191 is a synthetic peptide fragment corresponding to the terminal portion of the growth hormone sequence. This fragment is frequently utilized in controlled laboratory settings to study receptor interactions, peptide stability, and metabolic signaling pathways associated with truncated GH analogs.
Lyophilized powder supplied in standard laboratory vials.
Not for injection. Not for clinical or therapeutic use.
📌 Product Specifications
- Form: Lyophilized Powder
- Appearance: White Powder
- Purity: ≥ 98%
- Storage: Store in a cool, dry place. Refrigerate after reconstitution.
🔬 Research Applications
- Peptide–receptor interaction modeling
- Studies involving truncated GH fragments
- Investigations of laboratory-derived metabolic pathways
🧪 Molecular Details
- CAS Number: 87616-84-0
- Molecular Formula: C78H125N23O23S2
- Molecular Weight: 1817.12 g/mol
- Form: Lyophilized Powder
💡 Interested in the Science?
Explore current studies involving truncated GH fragments, peptide signaling pathways, and laboratory models assessing sequence-specific activity.








